2 results
Approved WMOCompleted
The primary objective is to evaluating the impact of treatment on subject reported outcomes of their satisfaction and experience of treatment with VOLUMA® with Lidocaine (2ml or 1ml or a combination of both), for the mid-face area volume enhancement…
Approved WMOCompleted
The purpose of Part A is to investigate how quickly and to what extent Rizatriptan in DFN-10 is absorbed and eliminated from the body (this is called pharmacokinetics). In addition, it will be investigated to what extent DFN-10 is tolerated.In Part…